Newly discovered protein may be therapeutic target for sepsis, other infections

The discovery of a protein showed signs of being a possible therapeutic target for monoclonal antibody treatment in sepsis cases as well as other infectious diseases, including COVID-19, according to research led by Haichao Wang, PhD, a professor and director of the laboratory of emergency medicine at Northwell Health’s Feinstein Institutes for Medical Research in Manhasset, N.Y.